Cetin, M. H., Rieckmann, T., Hoffer, K., Riepen, B., Christiansen, S., Gatzemeier, F., . . . Struve, N. (2023). G2 checkpoint targeting via Wee1 inhibition radiosensitizes EGFRvIII-positive glioblastoma cells. Radiation Oncology, 18(1), 1. https://doi.org/10.1186/s13014-023-02210-x
Chicago Style (17th ed.) CitationCetin, Meryem H., et al. "G2 Checkpoint Targeting via Wee1 Inhibition Radiosensitizes EGFRvIII-positive Glioblastoma Cells." Radiation Oncology 18, no. 1 (2023): 1. https://doi.org/10.1186/s13014-023-02210-x.
MLA (9th ed.) CitationCetin, Meryem H., et al. "G2 Checkpoint Targeting via Wee1 Inhibition Radiosensitizes EGFRvIII-positive Glioblastoma Cells." Radiation Oncology, vol. 18, no. 1, 2023, p. 1, https://doi.org/10.1186/s13014-023-02210-x.